3cck: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
{{Seed}}
[[Image:3cck.png|left|200px]]
[[Image:3cck.png|left|200px]]


<!--
The line below this paragraph, containing "STRUCTURE_3cck", creates the "Structure Box" on the page.
You may change the PDB parameter (which sets the PDB file loaded into the applet)
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
or leave the SCENE parameter empty for the default display.
-->
{{STRUCTURE_3cck|  PDB=3cck  |  SCENE=  }}  
{{STRUCTURE_3cck|  PDB=3cck  |  SCENE=  }}  


===Human CD69===
===Human CD69===


<!--
The line below this paragraph, {{ABSTRACT_PUBMED_18959746}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 18959746 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_18959746}}
{{ABSTRACT_PUBMED_18959746}}


==About this Structure==
==About this Structure==
3CCK is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3CCK OCA].  
[[3cck]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3CCK OCA].  
 
==Reference==
Soluble recombinant CD69 receptors optimized to have an exceptional physical and chemical stability display prolonged circulation and remain intact in the blood of mice., Vanek O, Nalezkova M, Kavan D, Borovickova I, Pompach P, Novak P, Kumar V, Vannucci L, Hudecek J, Hofbauerova K, Kopecky V Jr, Brynda J, Kolenko P, Dohnalek J, Kaderavek P, Chmelik J, Gorcik L, Zidek L, Sklenar V, Bezouska K, FEBS J. 2008 Nov;275(22):5589-606. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18959746 18959746]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Brynda, J.]]
[[Category: Brynda, J.]]
Line 40: Line 25:
[[Category: Transmembrane]]
[[Category: Transmembrane]]
[[Category: Tumor therapy]]
[[Category: Tumor therapy]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Dec  5 09:55:10 2008''